Streetbeat News

Regulatory

CZR

Caesars Entertainment, Inc. (NASDAQ:CZR) has launched its flagship sports wagering platform, Caesars Sportsbook, in Maine. The platform is now accepting sports wagers on mobile and desktop. The launch was made possible through a partnership with three of the Wabanaki Nations: the Houlton Band of Maliseet Indians, the Mi'kmaq Nation, and the Penobscot Nation. The revenues from sports wagering will be used by tribal governments and the State to support various sectors including law enforcement, health care, housing, and education throughout Maine.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:21 pm

ALPN

Alpine Immune Sciences presented new preclinical data on Povetacicept at the American Association of Neuromuscular & Electrodiagnostic Medicine 2023 Annual Meeting. The data showed that Povetacicept improved disease activity in a model of murine experimental autoimmune myasthenia gravis (EAMG), with clinical scores superior to treatment with either the FcRn inhibitor efgartigimod or an anti-CD20 depleting antibody. In the RUBY-1 clinical trial, Povetacicept was well tolerated in adult healthy volunteers and exhibited dose-related pharmacokinetic and pharmacodynamic effects.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:03 pm

AVGO

NFLX

The Munich District Court has ruled that Netflix (NFLX) infringes a patent owned by Broadcom (AVGO) related to digital video processing used in HEVC video coding. The court has issued an injunction requiring Netflix to cease and desist all further infringement. Broadcom has filed a motion seeking penalties for Netflix's non-compliance, which could include fines of up to €250,000 for each act of infringement and/or imprisonment for members of Netflix's board of directors.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:02 pm

HOWL

SQ

TNON

Block (SQ) shares are trading higher after reporting better-than-expected Q3 results and issuing Q4 guidance. Tenon Medical (TNON) passed a FDA Quality System Inspection Technique Level 2 Inspection. Werewolf Therapeutics (HOWL) presented preliminary data from a Phase 1/1b clinical trial at the Society for Immunotherapy of Cancer's annual meeting.

Portfolio Pulse from ryanfaloona@benzinga.com

November 03, 2023 | 12:54 pm

TNON

The FDA has completed a full Quality System Inspection Technique (QSIT) Level 2 inspection at Tenon Medical, a process used to assess a medical device manufacturer's compliance with quality system requirements and related regulations.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:42 pm

BCTX

BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW) (TSX:BCT) has reported unprecedented anti-tumor activity in tumor models by its next generation breast and prostate cancer immunotherapies. The FDA has authorized Bria-OTS™ Investigational New Drug Application (IND), opening the path to the clinic. The company's data shows broad immune system responses to the next generation immunotherapies compared with those of the earlier formulation. The company expects the administration of personalized BRIA-OTS+™ and BRIA-PROS+™ immunotherapies to provide safe and effective treatment options for cancer patients.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:35 pm

BAM

CCJ

Cameco and Brookfield Asset Management have received all necessary regulatory approvals for their joint acquisition of Westinghouse Electric Company. The transaction is expected to close on November 7. Cameco will finance its share of the acquisition using a $600 million term loan and available cash, and will not be utilizing the $280 million bridge commitment.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:33 pm

SPY

The USA participation rate for October was reported at 62.7%, slightly lower than the prior rate of 62.8%.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:30 pm

SPY

The USA Nonfarm Payrolls for October came in at 150K, lower than the estimated 180K and significantly below the prior figure of 297K.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:30 pm

SWAV

Shockwave Medical announced that the US Centers for Medicare & Medicaid Services has established a Category I Current Procedural Terminology Add On Code for Coronary Intravascular Lithotripsy Procedures, effective from January 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:20 pm